González de Dios J, Ochoa Sangrador C, en representación del Grupo de Trabajo (Grupo Investigador, Grupo de Revisión y Panel de Expertos) del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad y ADecuación) .

Recommendations of the Consensus Conference of Acute Bronchiolitis in Spain: from evidence to practice

Ochoa Sangrador C.

Diagnostic and therapeutic management of the urinary tract infection in childhood

Ochoa Sangrador C, Orejón de Luna G. The widespread application of preventive measures in pregnant women with human immunodeficiency virus infection may prevent its vertical transmission. Rev Pediatr Aten Primaria. 2008;10 Supl 1:s117-20

Orejón de Luna G, Ochoa Sangrador C. A quadrivalent vaccine against human papillomavirus, prevent high-grade malignancy cervical lesions associated to 16 an 18 serotypes, in young women without previous infection. Rev Pediatr Aten Primaria. 2008;10 Supl 1;S111-5

Orejón de Luna G, Ochoa Sangrador C. Vaccination against rubella in pregnant women is not associated to adverse effects. Rev Pediatr Aten Primaria. 2008;10 Supl 1:S101-4

Ochoa Sangrador C, Castro Rodríguez JA. Chest radiography has little clinical application in pattients with mild-moderate bronchiolitis without risk factors. Rev Pediatr Aten Primaria. 2008;10 Supl 1:S67-70

Ochoa Sangrador C, Castro Rodríguez JA. Corticosteroids are not effective in acute bronchiolitis. Rev Pediatr Aten Primaria. 2008;10 Supl 1:S55-9

Ochoa Sangrador C. Are clinically useful the imaging test we use in patients with urinary tract infection?. Rev Pediatr Aten Primaria. 2008;10Supl 1:S33-46

Ochoa Sangrador C. How much does child day-care center attendance increases the risk of acute otitis media?. Rev Pediatr Aten Primaria. 2007;9:683-91

Ochoa Sangrador C, Martín Muñoz P, Ruiz-Canela Cáceres J, Buñuel Álvarez JC. Critical appraisal of scientific literature. Rev Pediatr Aten Primaria. 2007;9 Supl 2:S151-60

González de Dios J, Ochoa Sangrador C, Balaguer Santamaría A. Respiratory syncytial virus prophylaxis with monoclonal antibodies (palivizumab) in congenital cardiopathies: critical review of efficacy, effectiveness, efficiency and safety. Rev Pediatr Aten Primaria. 2007;9:71-100